Gene Query: TBXAS1

Dataset Description Geneva Score
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 51.05
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 43.62
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 41.34
Effects of rFVIIIFc on human macrophages 36.72
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 36.68
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 36.68
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 28.1
CircRNAome diversity in human mature B-cells, T-cells and monocytes 26.94
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 26.29
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 23.68
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 22.23
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 22.23
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 21.85
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 20.96
Differential analysis of gene regulation at transcript resolution by RNA-Seq 20.96
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 20.64
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 18.51
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 18.51
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 18.31
RNA-seq of human fibroblasts after irradiation 18.09
Human cells contain natural double-stranded RNAs with potential regulatory capacity 16.91
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 16.82
Intron retention induced by microsatellite expansions as a disease biomarker. 16.16
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 16.02
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 15.52
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 15.03
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 14.88
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 14.6
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 14.54
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 14.54
Transcriptome wide analysis of classically and alternatively activated macrophages 14.5
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 14.5
Generation and functional characterization of MDSC-like cells 14.22
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 14.16
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 13.93
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 13.79
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 13.75
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 13.73
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 13.7
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 13.51
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 13.51
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 13.51
Control of prostate tumour growth by the long non-coding RNA GHSROS 13.36
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 13.33
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 13.29
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 13.29
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 13.21
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 13.17
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 12.93
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 12.82
Transcriptional profiling of microglia; current state of the art and future perspectives 12.76
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 12.43
A map of gene expression in neutrophil-like cell lines 12.42
RNA-seq of stable and unstable section of human atherosclerotic plaques 12.39
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 12.06
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 12.06
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 12.03
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 12.03
Paxillin regulates genomic networks in prostate cancer [PC3] 11.65
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 11.61
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 11.48
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 11.48
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 11.36
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 11.23
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 10.88
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 10.86
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 10.15
RNA-Seq from human ILC transitional populations 10.15
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 9.89
Differential expression of genes in AD169-infected MRC5. 9.88
Aging-associated patterns in the expression of human endogenous retroviruses 9.78
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 9.49
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 9.4
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 9.4
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 9.26
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 9.21
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 9.2
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 9.13
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 9.12
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 9.03
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 9.0
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 8.9
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 8.58
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 8.29
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 8.2
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 8.17
Microglia innatly develop within cerebral organoids 8.16
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 8.14
Dynamic 3D chromosomal landscapes in acute leukemia 8.14
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.08
Efficient derivation of microglia-like cells from human pluripotent stem cells 7.96
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 7.94
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.91
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 7.81
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 7.77
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.52
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.52
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.49
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 7.41
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.39
Single cell transcriptome of peritoneal cells 7.34
Identification of renal resident macrophages across species 7.23
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 7.2
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 7.2
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 7.08
Role of CD133 molecule in WNT response and renal repair 7.05
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 7.03
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 7.03
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.97
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.85
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.85
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 6.82
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 6.74
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 6.72
Reprogrammed myeloid cell transcriptomes in NSCLC 6.59
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 6.55
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 6.5
Genome-wide discovery of human splicing branchpoints 6.49
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 6.46
Transcriptional profile in human S. haematobium infection 6.44
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 6.42
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 6.41
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 6.4
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 6.34
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  6.31
MEIS1 regulates hematopoiesis in hPSCs 6.29
RNA-seq of Single-Cell Genotyping of Transcriptomes 6.27
Single-Cell Genotyping of Transcriptomes 6.27
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.26
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.26
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 6.25
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.25
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 6.24
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 6.2
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 6.11
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 6.11
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 6.01
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.0
RNA-seq melanoma 5.98
MYCi361 regulates MYC target genes 5.95
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 5.89
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.88
Short and Long RNA sequencing of human mature erythrocytes 5.88
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.81
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 5.8
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 5.8
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.75
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 5.68
Effect of mitochondria deficiency on senescence-associated gene expression 5.66
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 5.6
Identification of Sin3B regulated genes during quiescence 5.56
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.4
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.39
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 5.35
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 5.35
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 5.33
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 5.13
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 5.13
Macrophage Ad5f35 M2 Challenge 5.13
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.11
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.11
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 5.11
RNA seq comparison between scrambled and shGRP78 cells 5.09
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 5.09
Characterization of human ILC2 subsets 5.04
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 4.99
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 4.99
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 4.99
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 4.91
RNA-seq in HepG2 and IMR90 cells 4.91
Evolution of a transcriptional regulator from a transmembrane nucleoporin 4.91
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 4.83
Tpl-2 small molecule project 4.77
Tpl-2 and MEK small molecule inhibitors 4.77
Expression profiling of etoposide-induced senescent cells 4.74
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 4.72
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 4.72
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.7
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.7
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.63
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 4.61
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.61
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.61
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 4.6
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 4.49
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 4.47
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 4.4
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.32
Transcriptome analysis of peripheral blood monocytes 4.28
Differential gene expression profiles in imatinib-resistant cell lines 4.15
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 4.13
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 4.07
Transcriptome of Stabilin-1 siRNA transfected human monocytes 4.06
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 4.0
RNA-seq analysis of AML cells in response to ASLAN003 3.98
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 3.98
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 3.97
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 3.95
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 3.91
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.86
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 3.78
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 3.71
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 3.66
ML29755 RNA-seq data 3.61
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 3.59
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 3.58
An acquired vulnerability of drug resistant melanoma with therapeutic potential 3.58
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.58
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.58
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.56
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.53
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.53
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.52
Transcriptome analysis of SKI knock-out in HL60 cells 3.52
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 3.48
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.45
NAPRT activation of macrophages 3.44
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 3.43
RNA sequencing of human pancreatic cancer cell lines 3.43
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 3.42
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.37
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.36
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 3.34
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 3.29
Effect of Hotair overexpression in human breast cancer cell lines 3.21
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 3.2
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.19
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 3.19
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.17
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.17
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.16
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 3.15
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 3.14
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 3.12
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 3.11
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 3.1
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 3.08
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 3.06
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 3.06
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 3.02
oxLDL exposed trained monocytes 3.01
Transcriptomes of oxLDL exposed trained monocytes 3.01
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 2.97
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 2.97
Bone marrow derived human B cells [normal proB] 2.9
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 2.82
Neurofibroma 2.82
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 2.82
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 2.81
Macrophage Ad5f35 PhenoMap 2.8
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.77
TGF-β promotes genomic instability after loss of RUNX3 2.73
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 2.73
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.71
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.7
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.69
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.69
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 2.66
X-Ray induced DNA-Hydroxymethylation changes 2.64
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 2.64
RNA-seq of CD33 KO and control HSPCs 2.61
Irf9 function in immunity in mouse 2.61
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 2.61
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.61
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.6
Expression data from miR340 overexpressing human A549 cells 2.58
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.57
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 2.57
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 2.57
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 2.56
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.5
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 2.47
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 2.47
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 2.46
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.46
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.46
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.43
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.42
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.4
RNA-Seq and expression data from human adipose tissue 2.4
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.4
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 2.39
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.38
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.37
Overexpression and knockdown experiment for circCSNK1G3 2.36
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.33
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 2.31
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.29
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 2.28
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.27
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.27
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.25
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 2.23
Nucleoporin-mediated regulation of cell identity genes 2.23
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.21
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.15
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.15
Dysregulated immune system networks in war veterans with PTSD 2.09
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.08
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.07
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 2.07
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.05
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.03
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 2.01
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 2.0
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 1.99
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.98
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.98
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.97
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.94
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 1.93
Comparison of microRNA Profiling Platforms 1.91
Comparison of microRNA Profiling Platforms (HTS) 1.91
Gene expression signatures of innate lymphoid cells from human blood 1.89
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.85
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.82
RNA-seq in endometrial stromal tumors 1.81
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.79
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.78
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.76
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 1.73
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 1.72
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 1.72
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.72
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.72
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.72
Trascriptome of thyroid cancer-induced macrophages 1.69
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 1.67
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.65
Identification of renal resident macrophages across species [C1] 1.62
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.61
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.6
Transcriptomes of human monocytes after ex vivo exposure to uric acid 1.59
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.59
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.58
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 1.57
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 1.57
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 1.56
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.55
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.55
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.55
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 1.46
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.46
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.44
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.44
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.41
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.41
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.38
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.38
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.38
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 1.37
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 1.37
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.35
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.34
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.31
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 1.31
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.29
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.24
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.24
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.23
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.21
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.21
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 1.2
Direct Isolation and Characterization of Human Nephron Progenitors. 1.17
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.16
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.14
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.14
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.14
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 1.12
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.12
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.11
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 1.11
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 1.08
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.07
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.07
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.06
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.04
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.02
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.02
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.01
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.98
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.98
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.97
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.97
Leucegene: AML sequencing (part 6) 0.97
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.95
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.95
The DNA methylation landscape of human melanoma [RNA-Seq] 0.95
The DNA methylation landscape of human melanoma 0.95
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.92
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.92
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.91
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.91
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.89
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.89
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.89
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.88
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.88
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.85
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.85
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.85
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.83
Multiple sclerosis and EAE 0.83
Human optic chiasm from healthy controls and multiple sclerosis patients 0.83
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.82
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.8
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.8
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.79
Impact on erythroid progenitor type on erythroid differntiation 0.79
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.78
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.75
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.75
MAIT cell RNA sequencing 0.75
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.74
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.73
JAK dependent survival of ALK- ALCL 0.72
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.72
Single-cell analysis of adult human ovary using 10X genomics 0.72
RNA-Seq of the corpus callosum from 12 individuals 0.69
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.68
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.66
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.66
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.65
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.63
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.62
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 0.62
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.61
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 0.59
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.58
Patient-derived xenograft platform for metastatic melanoma 0.57
Common inflammatory pathways between NEC and Crohn's disease 0.57
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.57
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.56
A single cell reference map for human blood and tissue T cell activation 0.56
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 0.55
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.53
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.53
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.52
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.5
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.48
Hepatosplenic T cell lymphoma 0.48
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 0.48
quanTIseq: quantifying immune contexture of human tumors 0.48
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 0.48
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.47
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.47
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.44
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.44
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.43
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.43
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.42
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.41
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 0.4
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.4
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 0.37
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.36
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.35
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.35
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.33
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.32
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 0.32
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.31
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.3
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.29
Analyses of T-ALL (COG study) 0.28
RNA sequencing of T-ALL (COG study) 0.28
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.27
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.25
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.23
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.22
Transcriptomic profiling of human peripheral blood-derived mast cells 0.22
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.21
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.2
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.2
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.16
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.16
Specific molecular signatures underlie response to decitabine in CMML 0.16
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.15
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.15
RNA-seq of primary patient AML samples 0.15
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 0.14
Leucegene: ALL sequencing 0.13
Clinker: visualizing fusion genes detected in RNA-seq data 0.13
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.11
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.11
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.11
Expression patterns in chronic thromboembolic pulmonary hypertension 0.1
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.09
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.09
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.07
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.07
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.05
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.04
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.04
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.04
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.03
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.02
Expression analysis of the TAF1 syndrome 0.0
Anti-inflammatory effect of indoleacrylic acid (IA) 0.0
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation